Pharmaceutical
| Thu 22 Jan 2026
Beijing, Jan. 23 -- Suzhou Medinoah Co Ltd, Shandong Longchen Pharmaceutical Co Ltd and Pumeirui Suzhou Biotechnology Co Ltd have submitted a patent application for 1-oxoisoindoline Derivative and Application Thereof. Gao Yang, Mi Jinran, Zhou Zhuqing, Bao Weiguo, Wang Shiwei, Cao Qingqing, Chen Bailing, Zhou Jie, Kong Ren, Piao..